Molecular engineering of exocytic vesicle traffic enhances the productivity of Chinese hamster ovary cells
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
A complex vesicle trafficking system manages the precise and regulated distribution of proteins, membranes and other molecular cargo between cellular compartments as well as the secretion of (heterologous) proteins in mammalian cells. Sec1/Munc18 (SM) proteins are key components of the system by regulating membrane fusion. However, it is not clear how SM proteins contribute to the overall exocytosis. Here, functional analysis of the SM protein Sly1 and Munc18c suggested a united, positive impact upon SNARE‐based fusion of ER‐to‐Golgi‐ and Golgi‐to‐plasma membrane‐addressed exocytic vesicles and increased the secretory capacity of different therapeutic proteins in Chinese hamster ovary cells up to 40 pg/cell/day. Sly1‐ and Munc18c‐based vesicle traffic engineering cooperated with Xbp‐1‐mediated ER/Golgi organelle engineering. Our study supports a model for united function of SM proteins in stimulating vesicle trafficking machinery and provides a generic secretion engineering strategy to improve biopharmaceutical manufacturing of important protein therapeutics. Biotechnol. Bioeng. 2009;102: 1170‐1181. © 2008 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Production of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764 · cited 2×
“Most successful examples include (i) transcription engineering using trigger-inducible expression systems (Schlatter and Fussenegger, 2003), (ii) translation engineering consisting of improving ribosomal entry and translationinitiation (Underhill et al., 2003; Umaña et al., 1999),”
MethodSnares and Munc18 in synaptic vesicle fusion
Rizo, J., & Südhof, T. C. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn898 · Cited by 539
The phagosome: compartment with a license to kill
Haas, A. (2007) · Traffic · doi:10.1111/j.1600-0854.2006.00531.x · Cited by 450
Munc18-1 Promotes Large Dense-Core Vesicle Docking
Voets, T., Toonen, R. F., Brian, E. C., de Wit, H., Moser, T., Rettig, J., Südhof, T. C., Neher, E., & Verhage, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00391-9 · Cited by 396 · cited 7×
“For example, both promotive and inhibitory fusion control has been shown for Munc18a (Shen et al., 2007; Voets et al., 2001; Yang et al., 2000) whereas exclusive evidence for an inhibitory role in exocytosis by Munc18b/c has been reported (Kanda et al., 2005; Riento et al., 2000; Tellam et al., 1997; Thurmond et al.,…”
BackgroundInfluentialTigges, M., & Fussenegger, M. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2006.01.006 · Cited by 178 · cited 5×
“…as well as Xbp-1 which we have recently identified to boost protein secretion by increasing the size of secretory organelles (Shaffer et al., 2004; Tigges and Fussenegger, 2006) have different targets in the secretory pathway they might be able to synergistically enhance protein production.”
BackgroundSelf-citation
Cited by
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801
Expression systems for therapeutic glycoprotein production
Durocher, Y., & Butler, M. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.008 · Cited by 386
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
A Consensus Genome-scale Reconstruction of Chinese Hamster Ovary Cell Metabolism
Hefzi, H., Ang, K. S., Hanscho, M., Bordbar, A., Ruckerbauer, D., Lakshmanan, M., Orellana, C. A., Baycin-Hizal, D., Huang, Y., Ley, D., et al. (2016) · Cell Systems · doi:10.1016/j.cels.2016.10.020 · Cited by 255
CHO cell engineering to prevent polypeptide aggregation and improve therapeutic protein secretion
Le Fourn, V., Girod, P.-A., Buceta, M., Regamey, A., & Mermod, N. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.003 · Cited by 144
Dreesen, I. A. J., & Fussenegger, M. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22990 · Cited by 110
Self-citationDoolan, P., Meleady, P., Barron, N., Henry, M., Gallagher, R., Gammell, P., Melville, M., Sinacore, M., McCarthy, K., Leonard, M., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22670 · Cited by 84
Differential effect of exocytic SNAREs on the production of recombinant proteins in mammalian cells
Peng, R., Abellan, E., & Fussenegger, M. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22986 · Cited by 61
Self-citationFan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35
Metadata
- Authors
- Peng, R., & Fussenegger, M.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2008-11-06
- Volume
- 102
- Issue
- 4
- Pages
- 1170-1181
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2151722718
- Cited by
- 70
- References
- 6
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.